choline has been researched along with Pulmonary Alveolar Proteinosis in 1 studies
Pulmonary Alveolar Proteinosis: A PULMONARY ALVEOLI-filling disease, characterized by dense phospholipoproteinaceous deposits in the alveoli, cough, and DYSPNEA. This disease is often related to, congenital or acquired, impaired processing of PULMONARY SURFACTANTS by alveolar macrophages, a process dependent on GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corkill, DJ | 1 |
| Hunt, AN | 1 |
| Hinrichs, MJ | 1 |
| White, N | 1 |
| Rebelatto, M | 1 |
| Roskos, L | 1 |
| Nys, J | 1 |
| Scott, A | 1 |
| Robinson, MJ | 1 |
| Ryan, P | 1 |
| Postle, AD | 1 |
| Sleeman, MA | 1 |
1 other study available for choline and Pulmonary Alveolar Proteinosis
| Article | Year |
|---|---|
Chronic pharmacological antagonism of the GM-CSF receptor in mice does not replicate the pulmonary alveolar proteinosis phenotype but does alter lung surfactant turnover.
Topics: Animals; Antibodies, Monoclonal, Humanized; Arthritis, Rheumatoid; Autoantibodies; Bronchoalveolar L | 2021 |